查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1753302

全球抗菌止血凝胶市场

Antibacterial Hemostatic Gels
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 290 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球抗菌止血凝胶市场规模将达20亿美元

全球抗菌止血凝胶市场规模预计在2024年为14亿美元，到2030年将达到20亿美元，在2024-2030年的分析期间内，复合年增长率为5.5%。尿液检查套件是本报告分析的细分市场之一，预计其复合年增长率为6.6%，到分析期结束时将达到7.529亿美元。血液学检测套组细分市场在分析期间的复合年增长率预计为6.1%。

美国市场规模估计为 3.936 亿美元，中国市场预期复合年增长率为 8.9%

美国抗菌止血凝胶市场规模预计2024年达到3.936亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到4.048亿美元，在2024-2030年的分析期内，复合年增长率为8.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.6%和5.5%。在欧洲，预计德国市场的复合年增长率为3.6%。

全球抗菌止血凝胶市场－主要趋势与驱动因素摘要

抗菌止血凝胶如何改变伤口处理通讯协定？

抗菌止血凝胶作为突破性的伤口护理产品，正逐渐兴起，兼具快速止血和感染控制两大重要功能。传统伤口管理需要多个步骤和独立的产品，一个用于止血，另一个用于抑制细菌生长。这些新型凝胶透过提供一体化解决方案，消除了这种细分步骤的需要，大大简化了急诊和外科护理。这些凝胶背后的技术通常基于天然或合成聚合物，这些聚合物能够快速吸收血液，激活凝血机制，并同时释放抗菌剂以降低感染风险。它们在时间紧迫和高感染风险的情况下尤其有用，例如创伤、战场损伤、外科手术和慢性伤口护理。护理人员和战地医护人员使用它们在病人入院前快速稳定病情。它们易于用注射器或管子涂抹，因此在非医疗环境中也易于操作。临床试验表明，其中一些凝胶可以在60秒内止血，同时保持广谱抗菌功效。此外，它们还可以减少全身性抗生素的需求，这在抗生素抗药性日益受到关注的背景下尤其重要。随着伤口处理通讯协定的演变，抗菌止血凝胶的双重功效正迅速被应用于创伤套件、手术用套件和军事医疗用品中，这标誌着现代医学在出血和感染疾病治疗方式上的模式转移。

这项突破背后有哪些科学进步？

抗菌止血凝胶的兴起很大程度上归功于生医材料科学和奈米技术的突破，这些突破促进了多功能生物活性化合物的开发。这些凝胶通常由几丁聚醣、明胶、胶原蛋白等生物聚合物或能与人体凝血系统主动相互作用的合成衍生物所组成。为了增强抗菌活性，在凝胶基质中嵌入了银奈米颗粒、氧化锌和其他广谱抗菌剂。有些配方利用生物响应释放机制，仅在检测到特定环境因素（如 pH 值或细菌活动变化）时释放抗菌剂。这种精确性降低了细胞毒性并提高了治疗效果。此外，研究人员已经开始加入具有靶向抗菌特性的胜肽和酶，使它们能够主动破坏生物膜形成并抑制抗药性菌株，如 MRSA 和铜绿假单胞菌。另一个重要进展是加入模拟凝血酶和纤维蛋白原等天然凝血因子的止血剂，促进出血性疾病患者的凝血。一些产品被设计为生物分解性和可吸收，无需移除，并最大限度地减少疤痕。这些科学创新不仅提升了产品性能，也拓展了从战场和急救到术后伤口处理甚至牙科护理的潜在使用案例。凝胶黏度、组织黏附性和热稳定性的持续改进，进一步支持了其在传统医院环境和行动医疗单位中的应用。因此，这些创新不仅使抗菌止血凝胶更有效，而且用途更广泛，为其在医疗保健各个领域的应用铺平了道路。

为什么医疗保健产业迅速采用这种凝胶？

医疗产业对抗菌止血凝胶的快速采用，可归因于临床需求、经济价值和监管支持的共同作用。医院、外科中心和创伤科室面临着巨大的压力，需要在控製成本和严格遵守手术计画的同时，降低感染率、改善病患预后。这些凝胶提供了一种高效的解决方案，同时解决了伤口护理中最重要的两个问题：止血和预防感染。这种双重功能显着减少了每位患者使用的产品数量，简化了库存，并降低了整体护理成本。从工作流程的角度来看，这些凝胶的易用性和快速应用性可以缩短手术时间，并最大限度地降低高血容量手术中併发症的风险。由于其挽救生命的潜力和经过验证的安全性，许多凝胶已获得加速核准。此外，微创手术的兴起也催生了对能够在狭窄解剖空间内快速精准应用的产品的需求。公共卫生系统也逐渐认识到它们在灾难准备和紧急医疗服务中的价值。各国政府已开始储备这种凝胶，将其作为国家创伤套件的一部分，尤其是在易受自然灾害和衝突影响的国家。此外，随着人们对医院内感染 (HAI) 的认识不断提高，以及抗生素管理政策的推广，医院正在实施全面的创伤护理解决方案。在医疗资源有限的新兴国家，这种多用途凝胶是一种以更少的设备和更少的专业培训提供有效创伤护理的有效方法。抗菌止血凝胶的扩充性、高效性和临床多功能性使其成为各级医疗保健领域极具吸引力的解决方案。

推动抗菌止血凝胶市场成长的关键因素有哪些？

抗菌止血凝胶市场的成长受到多种因素的驱动，这些因素源于技术进步、临床通讯协定的变更以及医疗保健重点的不断演变。首先，道路交通事故、工业事故、衝突地区等造成的创伤性损伤不断增加，对兼具感染控制功能的快速反应止血产品的需求持续增长。其次，全球外科手术（包括择期手术和急诊手术）的增多，扩大了这些凝胶在医院和门诊的应用。第三，持续存在的全球抗生素抗药性挑战已将临床重点转向局部抗菌解决方案，而这些凝胶提供了一种在不影响感染控制的情况下减少全身性抗生素使用的可行方法。第四，生医材料工程的发展使得生产出不仅高效、经济高效且在各种温度和环境条件下稳定的凝胶成为可能。第五，军事和战术医疗计画的扩展发挥了关键作用，全球各国国防部门都将这些凝胶纳入士兵和医护人员的野战套件中。第六，患者偏好不断演变，越来越多的人寻求能够更快康復、更低併发症风险和更少疼痛的治疗方法。第七，门诊和家庭医疗保健服务的成长正在开闢新的分销管道，对用户友好型多功能创伤护理产品的需求旺盛。最后，医疗保健投资者的大力支持以及生物技术公司与医疗机构之间的研发合作正在加速产品创新和市场渗透。这些因素共同推动了抗菌止血凝胶的强劲成长，使其成为已开发国家和开发中国家现代创伤护理的重要组成部分。

部分

产品（尿液分析检测套组、血液学检测套组、血压监测设备、血糖监测设备、其他产品）；最终用途（居家医疗最终用途、诊断中心最终用途、医院最终用途、诊所最终用途、其他最终用途）

受访公司范例（41家值得关注的公司）

  • 3M Company
  • Baxter International Inc.
  • BioTime, Inc.
  • CR Bard, Inc.（Becton Dickinson）
  • ConvaTec Group Plc
  • DePuy Synthes（Johnson & Johnson）
  • Fumedica AG
  • Haemonetics Corporation
  • HEMOTECH Biomed Pvt Ltd
  • Integra LifeSciences
  • Johnson & Johnson
  • Medtronic plc
  • Molnlycke Health Care
  • Novosorb Biodegradable Products
  • OMRON Corporation
  • Pfizer Inc.
  • Porcine Biotech
  • Smith & Nephew plc
  • Stryker Corporation
  • WoundCare Technologies

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP36169

Global Antibacterial Hemostatic Gels Market to Reach US$2.0 Billion by 2030

The global market for Antibacterial Hemostatic Gels estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Urinanalysis Testing Kits, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$752.9 Million by the end of the analysis period. Growth in the Hematology Testing Kits segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$393.6 Million While China is Forecast to Grow at 8.9% CAGR

The Antibacterial Hemostatic Gels market in the U.S. is estimated at US$393.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$404.8 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Antibacterial Hemostatic Gels Market - Key Trends & Drivers Summarized

How Are Antibacterial Hemostatic Gels Transforming Wound Management Protocols?

Antibacterial hemostatic gels are emerging as a revolutionary class of wound care products that combine two critical functionalities-rapid hemostasis and infection control. Traditionally, wound management has required multiple steps and separate products: one for stopping bleeding, and another to prevent bacterial growth. These new gels eliminate the need for such segmentation by providing an all-in-one solution, drastically simplifying emergency and surgical care. The technology behind these gels is often based on natural or synthetic polymers that can rapidly absorb blood, activate clotting mechanisms, and simultaneously release antimicrobial agents to reduce the risk of infection. They are particularly useful in trauma cases, battlefield injuries, surgical procedures, and chronic wound care, where time is of the essence and infection risk is high. One of the most impactful applications of these gels is in pre-hospital emergency care, where paramedics and field medics can use them to stabilize patients quickly before hospital admission. Their ease of application-typically through a syringe or tube-makes them user-friendly even in non-medical settings. Clinical trials have shown that some of these gels can stop bleeding in under 60 seconds while maintaining broad-spectrum antibacterial efficacy. Furthermore, they reduce the need for systemic antibiotics, which is especially important in light of growing concerns around antibiotic resistance. As wound management protocols evolve, the dual-action functionality of antibacterial hemostatic gels is rapidly being integrated into trauma kits, surgical packs, and military medical supplies, signaling a paradigm shift in how bleeding and infection are addressed together in modern medicine.

What Are the Scientific Advancements Powering This Breakthrough?

The rise of antibacterial hemostatic gels is largely attributable to breakthroughs in biomaterials science and nanotechnology, which have enabled the development of multifunctional, bioactive compounds. These gels typically comprise biopolymers like chitosan, gelatin, collagen, or synthetic derivatives that interact positively with the body’s clotting system. To enhance antimicrobial action, silver nanoparticles, zinc oxide, or other broad-spectrum antibacterial agents are embedded into the gel matrix. Some formulations utilize bioresponsive release mechanisms-delivering the antibacterial agent only when certain environmental cues, such as pH change or bacterial activity, are detected. This precision reduces cytotoxicity and enhances therapeutic efficiency. Additionally, researchers have begun integrating peptides and enzymes with targeted antibacterial properties, which can actively disrupt biofilm formation and inhibit resistant bacterial strains such as MRSA and Pseudomonas aeruginosa. Another important development is the incorporation of hemostatic agents that mimic natural clotting factors, such as thrombin or fibrinogen, to accelerate coagulation even in patients with bleeding disorders. Several products are being engineered to be biodegradable and reabsorbable, which eliminates the need for removal and minimizes scarring. These scientific innovations are not just improving product performance but are also expanding the potential use cases-from battlefield and emergency care to post-operative surgical wound management and even dental procedures. The continuous refinement of gel viscosity, tissue adhesion, and thermal stability further supports their adoption in both traditional hospital settings and mobile medical units. As a result, these innovations are not only making antibacterial hemostatic gels more effective but also more versatile, opening up avenues for applications across multiple fields of medicine.

Why Is the Healthcare Industry Rapidly Adopting These Gels?

The healthcare industry’s swift embrace of antibacterial hemostatic gels can be attributed to a convergence of clinical need, economic value, and regulatory support. Hospitals, surgical centers, and trauma units are under immense pressure to reduce infection rates and improve patient outcomes while managing costs and adhering to stringent procedural timelines. These gels offer a highly efficient solution by addressing two of the most critical concerns in wound care simultaneously: bleeding control and infection prevention. This dual capability significantly reduces the number of products used per patient, streamlining inventory and lowering overall treatment costs. From a workflow perspective, the ease of use and rapid application of gels can reduce procedural times in surgeries and minimize the risk of complications during high-blood-loss operations. The adoption is further accelerated by favorable regulatory classifications in several countries, with many gels receiving expedited approvals due to their life-saving potential and proven safety profiles. Additionally, the rise in minimally invasive procedures has created demand for products that can be applied quickly and with precision in constrained anatomical spaces-something these gels are uniquely suited for. Public health systems are also recognizing their value in disaster preparedness and emergency medical services. Governments are beginning to stockpile these gels as part of national trauma kits, especially in countries prone to natural disasters or conflict. Furthermore, increasing awareness of hospital-acquired infections (HAIs) and the push toward antimicrobial stewardship policies are encouraging hospitals to adopt integrated wound care solutions. In emerging economies, where medical resources are limited, these multipurpose gels present an efficient way to deliver effective wound care with fewer supplies and less specialized training. The scalability, efficiency, and clinical versatility of antibacterial hemostatic gels make them a highly attractive solution across all tiers of healthcare delivery.

What Are the Key Factors Driving Market Growth for Antibacterial Hemostatic Gels?

The growth in the antibacterial hemostatic gels market is driven by several factors rooted in technological advancements, changing clinical protocols, and evolving healthcare priorities. First, the increasing incidence of traumatic injuries-whether from road accidents, industrial mishaps, or conflict zones-is creating consistent demand for rapid-response hemostatic products that also provide infection control. Second, the rise in surgical procedures worldwide, including both elective and emergency surgeries, is expanding the application base for these gels in hospitals and outpatient settings. Third, the ongoing global challenge of antibiotic resistance has shifted clinical focus toward localized antimicrobial solutions, and these gels offer a viable way to reduce systemic antibiotic use without compromising infection control. Fourth, improvements in biomaterial engineering have allowed for the production of gels that are not only highly effective but also cost-efficient and stable across different temperatures and environmental conditions, which is crucial for their use in both developed and resource-limited healthcare systems. Fifth, the expansion of military and tactical medicine programs is playing a pivotal role, with defense departments across the world integrating these gels into field kits for soldiers and medics. Sixth, patient preferences are evolving, with more people seeking treatments that promise faster recovery, lower complication risks, and less pain-factors that these gels directly address. Seventh, the growth of outpatient clinics and home healthcare services is opening new distribution channels where user-friendly, multi-purpose wound care products are in high demand. Lastly, strong backing from healthcare investors, along with R&D collaborations between biotech firms and medical institutions, is accelerating product innovation and market penetration. These drivers, in tandem, are creating a robust growth trajectory for antibacterial hemostatic gels, positioning them as an indispensable component of modern wound care across both advanced and developing healthcare systems.

SCOPE OF STUDY:

The report analyzes the Antibacterial Hemostatic Gels market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Other Products); End-Use (Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use, Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • 3M Company
  • Baxter International Inc.
  • BioTime, Inc.
  • C.R. Bard, Inc. (Becton Dickinson)
  • ConvaTec Group Plc
  • DePuy Synthes (Johnson & Johnson)
  • Fumedica AG
  • Haemonetics Corporation
  • HEMOTECH Biomed Pvt Ltd
  • Integra LifeSciences
  • Johnson & Johnson
  • Medtronic plc
  • Molnlycke Health Care
  • Novosorb Biodegradable Products
  • OMRON Corporation
  • Pfizer Inc.
  • Porcine Biotech
  • Smith & Nephew plc
  • Stryker Corporation
  • WoundCare Technologies

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Antibacterial Hemostatic Gels - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Surgical Volumes and Wound Management Needs Throw the Spotlight on Antibacterial Hemostatic Gels
    • Use in Trauma, Orthopedics, and Cardiac Surgeries Expands Market Relevance Across Specialties
    • OEMs Offering Dual-Action Hemostasis and Infection Control Enhance Surgical Efficiency
    • Growth in Emergency and Battlefield Medicine Drives Demand for Rapid-Action Gel Formulations
    • Use of Biocompatible Polymers and Silver-Based Agents Enhances Healing Outcomes
    • OEM Emphasis on Preloaded Syringes and Easy Applicators Improves OR Workflow
    • Rising Focus on Reducing Surgical Site Infections Drives Adoption of Antibacterial Technologies
    • Use in Robotic and Laparoscopic Procedures Promotes Precision Application
    • Expansion of Field Use in Remote and Resource-Limited Settings Supports Global Adoption
    • OEMs Integrating Hemostatic Gels With Advanced Wound Closure Systems Add Value to Surgical Kits
    • Use in Dental, ENT, and Neurosurgery Diversifies Clinical Use Cases
    • Growing Demand for Reabsorbable and Non-Animal-Sourced Formulations Broadens Patient Eligibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Antibacterial Hemostatic Gels Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Antibacterial Hemostatic Gels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Urinanalysis Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Urinanalysis Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Urinanalysis Testing Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hematology Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hematology Testing Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hematology Testing Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Blood Pressure Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Blood Pressure Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Blood Pressure Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Blood Glucose Monitoring Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Blood Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Homecare End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Homecare End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Antibacterial Hemostatic Gels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: France 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: France 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Australia 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: India 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: India 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: South Korea 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Antibacterial Hemostatic Gels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Argentina 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Brazil 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Mexico 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Antibacterial Hemostatic Gels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Iran 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Israel 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: UAE 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Antibacterial Hemostatic Gels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Antibacterial Hemostatic Gels by Product - Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Antibacterial Hemostatic Gels by Product - Percentage Breakdown of Value Sales for Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices and Other Products for the Years 2014, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Antibacterial Hemostatic Gels by End-Use - Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Africa 16-Year Perspective for Antibacterial Hemostatic Gels by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Homecare End-Use, Diagnostic Centers End-Use, Hospitals End-Use and Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION